Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management.
Rev Esp Cardiol (Engl Ed)
; 76(7): 555-563, 2023 Jul.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: covidwho-2251320
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has revealed several cardiovascular complications, including myocarditis caused by SARS-CoV-2 infection (COVID-19) or after messenger RNA vaccine administration. Because of the high prevalence of COVID-19, the expansion of vaccination programs, and the appearance of new information on myocarditis in these contexts, there is a need to condense the knowledge acquired since the start of the pandemic. To meet this need, this document was drafted by the Myocarditis Working Group of the Heart Failure Association of the Spanish Society of Cardiology, with the collaboration of the Spanish Agency for Medicines and Health Products (AEMPS). The document aims to address the diagnosis and treatment of cases of myocarditis associated with SARS-CoV-2 infection or messenger RNA vaccine administration.
Palavras-chave
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
MEDLINE
Assunto principal:
COVID-19
/
Miocardite
Tipo de estudo:
Estudo observacional
Tópicos:
Vacinas
Limite:
Humanos
Idioma:
Inglês
/
Espanhol
Revista:
Rev Esp Cardiol (Engl Ed)
Ano de publicação:
2023
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS